One approach to HIV vaccine development relies on broadly neutralizing antibodies (bnAbs) that protect against different circulating HIV strains. bnAbs have been isolated from HIV-infected individuals, but they are highly ...
Aug 25, 2016
0
3
One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can't seem to induce the same response.
Jul 29, 2016
0
137
It has remained frustratingly difficult to develop a vaccine for HIV/AIDS, in part because the virus, once in our bodies, rapidly reproduces and evolves to escape being killed by the immune system.
Jul 21, 2016
0
56
In a paper published in the July 14 inaugural issue of the journal Science Immunology, University of Alabama at Birmingham researchers report a new quality-control checkpoint function in developing B cells, cells that produce ...
Jul 14, 2016
0
17
The development of an effective vaccine to prevent HIV infections would represent a critical step toward ending the HIV/AIDS pandemic. Thus far, the only large clinical trial for an HIV vaccine to show promise was the RV144 ...
Jul 12, 2016
0
3
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...
May 4, 2016
0
82
Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis (infection of the brain) in Asia. There is no specific treatment for Japanese encephalitis (JE) which can cause death or serious long-term disability, ...
May 3, 2016
0
12
Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" ...
Mar 24, 2016
0
59
A normal, predominant bacterial species of the healthy vaginal microbiota can be engineered for potential use as a novel protective agent against HIV-1 transmission in women, according to a new publication from scientists ...
Mar 24, 2016
0
12
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
Mar 3, 2016
0
0
